PROM1 and colorectal neoplasm: In this way, EGCG (0–40 μM) suppresses Wnt/β-catenin axis to reduce expression levels of CD133, CD44, ALDHA1, Nanog and Oct4 in impairing CSC features in colorectal tumor [170].